Why BioNTech Stock Soared 46% in November
_0.png?locale=de){kind=logo}
Shares of German clinical-stage biotech BioNTech (NASDAQ: BNTX) soared 45.5% in November, according to data from S&P Global Market Intelligence.
For context, the S&P 500 returned 11% last month.
Image source: Getty Images.
Source Fool.com
